Role of collagen matrix in tumor angiogenesis and glioblastoma multiforme progression

American Journal of Pathology

Volumn 183, Issue 4, 2013, Pages 1293-1305

  Mammoto, Tadanori ^a   Jiang, Amanda ^a   Jiang, Elisabeth ^a   Panigrahy, Dipak ^a,b   Kieran, Mark W ^a,b   Mammoto, Akiko ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; COLLAGEN; PENICILLAMINE; PROTEIN LYSINE 6 OXIDASE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; CELL SHAPE; CELL SIZE; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; BRAIN; BRAIN NEOPLASMS; CELL COUNT; CELL LINE, TUMOR; COLLAGEN; DISEASE PROGRESSION; GLIOBLASTOMA; HUMANS; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PENICILLAMINE; PROTEIN-LYSINE 6-OXIDASE; STRESS, MECHANICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84884545390     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.06.026     Document Type: Article

References (71)

1. H. Zong, R.G. Verhaak, and P. Canoll The cellular origin for malignant glioma and prospects for clinical advancements Expert Rev Mol Diagn 12 2012 383 394
2. A. Behin, K. Hoang-Xuan, A.F. Carpentier, and J.Y. Delattre Primary brain tumours in adults Lancet 361 2003 323 331
3. G. Bergers, and D. Hanahan Modes of resistance to anti-angiogenic therapy Nat Rev Cancer 8 2008 592 603
4. W.Y. Kim, and H.Y. Lee Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors FEBS J 276 2009 4653 4664
5. D.A. Reardon, S. Turner, K.B. Peters, A. Desjardins, S. Gururangan, J.H. Sampson, R.E. McLendon, J.E. Herndon 2nd, L.W. Jones, J.P. Kirkpatrick, A.H. Friedman, J.J. Vredenburgh, D.D. Bigner, and H.S. Friedman A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma J Natl Compr Canc Netw 9 2011 414 427
6. A.K. Lucio-Eterovic, Y. Piao, and J.F. de Groot Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy Clin Cancer Res 15 2009 4589 4599
7. J.J. Verhoeff, O. van Tellingen, A. Claes, L.J. Stalpers, M.E. van Linde, D.J. Richel, W.P. Leenders, and W.R. van Furth Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme BMC Cancer 9 2009 444
8. J.J. Vredenburgh, A. Desjardins, J.E. Herndon 2nd, J.M. Dowell, D.A. Reardon, J.A. Quinn, J.N. Rich, S. Sathornsumetee, S. Gururangan, M. Wagner, D.D. Bigner, A.H. Friedman, and H.S. Friedman Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma Clin Cancer Res 13 2007 1253 1259
9. W.B. Pope, A. Lai, P. Nghiemphu, P. Mischel, and T.F. Cloughesy MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy Neurology 66 2006 1258 1260
10. J. Folkman Role of angiogenesis in tumor growth and metastasis Semin Oncol 29 2002 15 18
11. S. Goel, D.G. Duda, L. Xu, L.L. Munn, Y. Boucher, D. Fukumura, and R.K. Jain Normalization of the vasculature for treatment of cancer and other diseases Physiol Rev 91 2011 1071 1121
12. S. Huang, and D.E. Ingber Cell tension, matrix mechanics, and cancer development Cancer Cell 8 2005 175 176
13. A. Mammoto, and D.E. Ingber Cytoskeletal control of growth and cell fate switching Curr Opin Cell Biol 21 2009 864 870
14. D. Discher, C. Dong, J.J. Fredberg, F. Guilak, D. Ingber, P. Janmey, R.D. Kamm, G.W. Schmid-Schönbein, and S. Weinbaum Biomechanics: cell research and applications for the next decade Ann Biomed Eng 37 2009 847 859
15. K.R. Levental, H. Yu, L. Kass, J.N. Lakins, M. Egeblad, J.T. Erler, S.F. Fong, K. Csiszar, A. Giaccia, W. Weninger, M. Yamauchi, D.L. Gasser, and V.M. Weaver Matrix crosslinking forces tumor progression by enhancing integrin signaling Cell 139 2009 891 906
16. G. Cheng, J. Tse, R.K. Jain, and L.L. Munn Micro-environmental mechanical stress controls tumor spheroid size and morphology by suppressing proliferation and inducing apoptosis in cancer cells PLoS One 4 2009 e4632
17. D.T. Butcher, T. Alliston, and V.M. Weaver A tense situation: forcing tumour progression Nat Rev Cancer 9 2009 108 122
18. M. Hofmann, M. Guschel, A. Bernd, J. Bereiter-Hahn, R. Kaufmann, C. Tandi, H. Wiig, and S. Kippenberger Lowering of tumor interstitial fluid pressure reduces tumor cell proliferation in a xenograft tumor model Neoplasia 8 2006 89 95
19. M.J. Paszek, N. Zahir, K.R. Johnson, J.N. Lakins, G.I. Rozenberg, A. Gefen, C.A. Reinhart-King, S.S. Margulies, M. Dembo, D. Boettiger, D.A. Hammer, and V.M. Weaver Tensional homeostasis and the malignant phenotype Cancer Cell 8 2005 241 254
20. A. Mammoto, S. Huang, K. Moore, P. Oh, and D.E. Ingber Role of RhoA, mDia, and ROCK in cell shape-dependent control of the Skp2-p27kip1 pathway and the G1/S transition J Biol Chem 279 2004 26323 26330
21. C.M. Lo, H.B. Wang, M. Dembo, and Y.L. Wang Cell movement is guided by the rigidity of the substrate Biophys J 79 2000 144 152
22. A. Mammoto, K.M. Connor, T. Mammoto, C.W. Yung, D. Huh, C.M. Aderman, G. Mostoslavsky, L.E. Smith, and D.E. Ingber A mechanosensitive transcriptional mechanism that controls angiogenesis Nature 457 2009 1103 1108
23. H. Yu, J.K. Mouw, and V.M. Weaver Forcing form and function: biomechanical regulation of tumor evolution Trends Cell Biol 21 2011 47 56
24. A.C. Bellail, S.B. Hunter, D.J. Brat, C. Tan, and E.G. Van Meir Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion Int J Biochem Cell Biol 36 2004 1046 1069
25. I.J. Huijbers, M. Iravani, S. Popov, D. Robertson, S. Al-Sarraj, C. Jones, and C.M. Isacke A role for fibrillar collagen deposition and the collagen internalization receptor endo180 in glioma invasion PLoS One 5 2010 e9808
26. J. Zamecnik The extracellular space and matrix of gliomas Acta Neuropathol 110 2005 435 442
27. M.M. Smith, and B.K. Hall Development and evolutionary origins of vertebrate skeletogenic and odontogenic tissues Biol Rev Camb Philos Soc 65 1990 277 373
28. B.K. Hall, and T. Miyake The membranous skeleton: the role of cell condensations in vertebrate skeletogenesis Anat Embryol (Berl) 186 1992 107 124
29. T. Mammoto, A. Mammoto, Y.S. Torisawa, T. Tat, A. Gibbs, R. Derda, R. Mannix, M. de Bruijn, C.W. Yung, D. Huh, and D.E. Ingber Mechanochemical control of mesenchymal condensation and embryonic tooth organ formation Dev Cell 21 2011 758 769
30. A. Mammoto, T. Mammoto, M. Kanapathipillai, C. Wing Yung, E. Jiang, A. Jiang, K. Lofgren, E.P.S. Gee, and D.E. Ingber Control of lung vascular permeability and endotoxin-induced pulmonary oedema by changes in extracellular matrix mechanics Nature Commun 4 2013 1759
31. G. Helmlinger, P.A. Netti, H.C. Lichtenbeld, R.J. Melder, and R.K. Jain Solid stress inhibits the growth of multicellular tumor spheroids Nature Biotechnol 15 1997 778 783
32. J.M. Tse, G. Cheng, J.A. Tyrrell, S.A. Wilcox-Adelman, Y. Boucher, R.K. Jain, and L.L. Munn Mechanical compression drives cancer cells toward invasive phenotype Proc Natl Acad Sci U S A 109 2012 911 916
33. K.L. Sodek, M.J. Ringuette, and T.J. Brown Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype Int J Cancer 124 2009 2060 2070
34. P. Iyengar, V. Espina, T.W. Williams, Y. Lin, D. Berry, L.A. Jelicks, H. Lee, K. Temple, R. Graves, J. Pollard, N. Chopra, R.G. Russell, R. Sasisekharan, B.J. Trock, M. Lippman, V.S. Calvert, E.F. Petricoin 3rd, L. Liotta, E. Dadachova, R.G. Pestell, M.P. Lisanti, P. Bonaldo, and P.E. Scherer Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment J Clin Invest 115 2005 1163 1176
35. A. Shimizu, A. Mammoto, J.E. Italiano Jr., E. Pravda, A.C. Dudley, D.E. Ingber, and M. Klagsbrun ABL2/ARG tyrosine kinase mediates SEMA3F-induced RhoA inactivation and cytoskeleton collapse in human glioma cells J Biol Chem 283 2008 27230 27238
36. A. Mammoto, J.E. Sero, T. Mammoto, and D.E. Ingber Methods for studying mechanical control of angiogenesis by the cytoskeleton and extracellular matrix Methods Enzymol 443 2008 227 259
37. J.B. Rubin, A.L. Kung, R.S. Klein, J.A. Chan, Y. Sun, K. Schmidt, M.W. Kieran, A.D. Luster, and R.A. Segal A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors Proc Natl Acad Sci U S A 100 2003 13513 13518
38. J.T. Erler, K.L. Bennewith, M. Nicolau, N. Dornhofer, C. Kong, Q.T. Le, J.T. Chi, S.S. Jeffrey, and A.J. Giaccia Lysyl oxidase is essential for hypoxia-induced metastasis Nature 440 2006 1222 1226
39. B. Fogelgren, N. Polgár, K.M. Szauter, Z. Ujfaludi, R. Laczkó, K.S. Fong, and K. Csiszar Cellular fibronectin binds to lysyl oxidase with high affinity and is critical for its proteolytic activation J Biol Chem 280 2005 24690 24697
40. K. Atabai, S. Jame, N. Azhar, A. Kuo, M. Lam, W. McKleroy, G. Dehart, S. Rahman, D.D. Xia, A.C. Melton, P. Wolters, C.L. Emson, S.M. Turner, Z. Werb, and D. Sheppard Mfge8 diminishes the severity of tissue fibrosis in mice by binding and targeting collagen for uptake by macrophages J Clin Invest 119 2009 3713 3722
41. A. Mammoto, T. Mammoto, and D.E. Ingber Mechanosensitive mechanisms in transcriptional regulation J Cell Sci 125 2012 3061 3073
42. L. Yuan, M. Siegel, K. Choi, C. Khosla, C.R. Miller, E.N. Jackson, D. Piwnica-Worms, and K.M. Rich Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy Oncogene 26 2007 2563 2573
43. M. Kanapathipillai, A. Mammoto, T. Mammoto, J.H. Kang, E. Jiang, K. Ghosh, N. Korin, A. Gibbs, R. Mannix, and D. Ingber Inhibition of mammary tumor growth using lysyl oxidase-targeting nanoparticles to modify extracellular matrix Nano Lett 12 2012 3213 3217
44. C. Fornieri, M. Baccarani-Contri, D. Quaglino Jr., and I. Pasquali-Ronchetti Lysyl oxidase activity and elastin/glycosaminoglycan interactions in growing chick and rat aortas J Cell Biol 105 1987 1463 1469
45. H.M. Kagan, and P.C. Trackman Properties and function of lysyl oxidase Am J Respir Cell Mol Biol 5 1991 206 210
46. H.M. Kagan, and W. Li Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell J Cell Biochem 88 2003 660 672
47. W. Li, M.A. Nugent, Y. Zhao, A.N. Chau, S.J. Li, I.N. Chou, G. Liu, and H.M. Kagan Lysyl oxidase oxidizes basic fibroblast growth factor and inactivates its mitogenic potential J Cell Biochem 88 2003 152 164
48. E.H. Tchaparian, J.Y. Uriu-Adams, C.L. Keen, A.E. Mitchell, and R.B. Rucker Lysyl oxidase and P-ATPase-7A expression during embryonic development in the rat Arch Biochem Biophys 379 2000 71 77
49. D.A. Kirschmann, E.A. Seftor, S.F. Fong, D.R. Nieva, C.M. Sullivan, E.M. Edwards, P. Sommer, K. Csiszar, and M.J. Hendrix A molecular role for lysyl oxidase in breast cancer invasion Cancer Res 62 2002 4478 4483
50. L.F. Miller, M.D. Judge, and B.D. Schanbacher Intramuscular collagen and serum hydroxyproline as related to implanted testosterone, dihydrotestosterone and estradiol-17 beta in growing wethers J Anim Sci 68 1990 1044 1048
51. A.D. Norden, G.S. Young, K. Setayesh, A. Muzikansky, R. Klufas, G.L. Ross, A.S. Ciampa, L.G. Ebbeling, B. Levy, J. Drappatz, S. Kesari, and P.Y. Wen Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence Neurology 70 2008 779 787
52. P.C. Trackman, and H.M. Kagan Nonpeptidyl amine inhibitors are substrates of lysyl oxidase J Biol Chem 254 1979 7831 7836
53. T. Kosonen, J.Y. Uriu-Hare, M.S. Clegg, C.L. Keen, and R.B. Rucker Incorporation of copper into lysyl oxidase Biochem J 327 Pt 1 1997 283 289
54. A. Ala, A.P. Walker, K. Ashkan, J.S. Dooley, and M.L. Schilsky Wilson's disease Lancet 369 2007 397 408
55. S. Brem, S.A. Grossman, K.A. Carson, P. New, S. Phuphanich, J.B. Alavi, T. Mikkelsen, J.D. Fisher, and New Approaches to Brain Tumor Therapy CNS Consortium Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma Neuro Oncol 7 2005 246 253
56. I.K. Guttilla, K.N. Phoenix, X. Hong, J.S. Tirnauer, K.P. Claffey, and B.A. White Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs Breast Cancer Res Treat 132 2012 75 85
57. B.S. Croix, J.W. Rak, S. Kapitain, C. Sheehan, C.H. Graham, and R.S. Kerbel Reversal by hyaluronidase of adhesion-dependent multicellular drug resistance in mammary carcinoma cells J Natl Cancer Inst 88 1996 1285 1296
58. A. Ferrante, G. Rainaldi, P. Indovina, P.L. Indovina, and M.T. Santini Increased cell compaction can augment the resistance of HT-29 human colon adenocarcinoma spheroids to ionizing radiation Int J Oncol 28 2006 111 118
59. M.A. Taylor, J.D. Amin, D.A. Kirschmann, and W.P. Schiemann Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-beta signaling in breast cancer cells Neoplasia 13 2011 406-318
60. M. Giampuzzi, R. Oleggini, and A. Di Donato Altered adhesion features and signal transduction in NRK-49F cells transformed by down-regulation of lysyl oxidase Biochim Biophys Acta 1647 2003 239 244
61. A.M. Baker, D. Bird, J.C. Welti, M. Gourlaouen, G. Lang, G.I. Murray, A.R. Reynolds, T.R. Cox, and J.T. Erler Lysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesis Cancer Res 73 2013 583 594
62. C.Z. Chen, and M. Raghunath Focus on collagen: in vitro systems to study fibrogenesis and antifibrosis state of the art Fibrogenesis Tissue Repair 2 2009 7
63. K.V. Lu, J.P. Chang, C.A. Parachoniak, M.M. Pandika, M.K. Aghi, D. Meyronet, N. Isachenko, S.D. Fouse, J.J. Phillips, D.A. Cheresh, M. Park, and G. Bergers VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex Cancer Cell 22 2012 21 35
64. A. Jahangiri, M. De Lay, L.M. Miller, W.S. Carbonell, Y.L. Hu, K. Lu, M.W. Tom, J. Paquette, T.A. Tokuyasu, S. Tsao, R. Marshall, A. Perry, K.M. Bjorgan, M.M. Chaumeil, S.M. Ronen, G. Bergers, and M.K. Aghi Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance Clin Cancer Res 19 2013 1773 1783
65. L.M. Ellis, and D.A. Reardon Cancer: the nuances of therapy Nature 458 2009 290 292
66. G.J. Brewer Copper control as an antiangiogenic anticancer therapy: lessons from treating Wilson's disease Exp Biol Med (Maywood) 226 2001 665 673
67. C. Di Serio, L. Doria, S. Pellerito, I. Prudovsky, I. Micucci, D. Massi, M. Landriscina, N. Marchionni, G. Masotti, and F. Tarantini The release of fibroblast growth factor-1 from melanoma cells requires copper ions and is mediated by phosphatidylinositol 3-kinase/Akt intracellular signaling pathway Cancer Lett 267 2008 67 74
68. Q. Pan, C.G. Kleer, K.L. van Golen, J. Irani, K.M. Bottema, C. Bias, M. De Carvalho, E.A. Mesri, D.M. Robins, R.D. Dick, G.J. Brewer, and S.D. Merajver Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis Cancer Res 62 2002 4854 4859
69. T.T. Batchelor, A.G. Sorensen, E. di Tomaso, W.T. Zhang, D.G. Duda, K.S. Cohen, K.R. Kozak, D.P. Cahill, P.J. Chen, M. Zhu, M. Ancukiewicz, M.M. Mrugala, S. Plotkin, J. Drappatz, D.N. Louis, P. Ivy, D.T. Scadden, T. Benner, J.S. Loeffler, P.Y. Wen, and R.K. Jain AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients Cancer Cell 11 2007 83 95
70. S. Brem, A.M. Tsanaclis, and D. Zagzag Anticopper treatment inhibits pseudopodial protrusion and the invasive spread of 9L gliosarcoma cells in the rat brain Neurosurgery 26 1990 391 396
71. S.S. Brem, D. Zagzag, A.M. Tsanaclis, S. Gately, M.P. Elkouby, and S.E. Brien Inhibition of angiogenesis and tumor growth in the brain: suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor Am J Pathol 137 1990 1121 1142